Upgrade to SI Premium - Free Trial

Goldman Sachs Starts Versigent Ltd. (VGNT) at Buy

July 20, 2026 3:07 AM
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent Ltd. (NYSE: VGNT) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage